Where is Jagsonpal located?

Jagsonpal is headquartered in Delhi, India. It is registered at Innov8 3rd Floor, Plot No. 211, Okhla Phase-3, New Delhi, Okhla Industrial Estate, South Delhi, New Delhi, Delhi, India, 110020.

Which legal entities is Jagsonpal associated with?

Jagsonpal is associated with JAGSON PAL PHARMACEUTICALS LIMITED..

How many employees does Jagsonpal have?

As of Aug 31, 2025, the latest employee count at Jagsonpal is 1355.

What is the annual revenue of Jagsonpal?

Annual revenue of Jagsonpal is between ₹100 Cr and ₹500 Cr as on Mar 31, 2025

Where does Jagsonpal rank among its competitors?

Jagsonpal ranks 4th amongst 393 active competitors, of which 15 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Almac Group, which secured $417K in Sep, 2022.

Who are the top competitors of Jagsonpal?

Jagsonpal's top competitors include Concord Biotech, Biophore and Almac Group. Among them, Almac Group secured the most recent funding round in September, 2022.

Jagsonpal - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Jagsonpal is a traditional company engaged in manufacturing and marketing bulk drugs and finished formulations. The company has a portfolio of 9 API products and more than 200 finished formulation products. The company has operations in 13 countries spread across 3 continents apart from India. The company primarily offers contract manufacturing services to other pharma companies

Website: www.jagsonpal.com/
Social
Registered Address: Innov8 3rd Floor, Plot No. 211, Okhla Phase-3, New Delhi, Okhla Industrial Estate, South Delhi, New Delhi, Delhi, India, 110020

Key Metrics

Founded Year

1964

Location

Delhi, India

Stage

Public

Investors

Convergent & 1 more

Ranked

4^th among 393 active competitors

Annual Revenue

₹100 - ₹500 Cr as on Mar 31, 2025

Employee Count

1,355 as on Aug 31, 2025

Investment & Acquisitions

Group Pharma & 4 more

Similar Companies

Concord Biotech & 439 more

Exit Details

Public

View Jagsonpal's full profile

Jagsonpal is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
JAGSON PAL PHARMACEUTICALS LIMITED. CIN: L74899DL1978PLC009181 , India, Active	Aug 17, 1978	₹100 - ₹500 Cr (As on Mar 31, 2025)	1355 (As on Aug 31, 2025)

Jagsonpal got listed on May 27, 1987.

Click here to take a look at Jagsonpal's IPO in detail

Jagsonpal is a funded company. Jagsonpal has 2 institutional investors.

View details of Jagsonpal's funding rounds and investors

The founders of Jagsonpal is Rajpal singh kochar. Parveen Kaushal is the CEO of Jagsonpal.

Here are the details of Jagsonpal's key team members:

Rajpal singh kochar: Owner of Jagsonpal.
Parveen Kaushal: CEO of Jagsonpal.

View details of Jagsonpal's Founder profiles and Board Members

Jagsonpal's employee count trend

Jagsonpal has 1,355 employees as of Aug 25. The total employee count is 3.0% lower than what it was in Aug 24. Here is Jagsonpal's employee count trend over the years:

Uncover Jagsonpal's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Jagsonpal include Concord Biotech, Biophore and Almac Group. Here is the list of Top 10 competitors of Jagsonpal, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Concord Biotech 1984, Ahmedabad (India), Public	CDMO focused on manufacturing API	$11.3M	Quadria Capital, Helix Investments & 18 others	69/100
2nd	Biophore 2007, Hyderabad (India), Seed	Development and manufacturing of niche pharmaceutical products for the generic industry	$2.74M	Ontario & 6 others	62/100
3rd	Almac Group 2001, Craigavon (United Kingdom), Series D	CRAMS company offering preclinical development and CDMO services, also offering companion diagnostic development	$339M	Genomic Health, Gates & 4 others	57/100
4th	Jagsonpal 1964, Delhi (India), Public	Traditional company manufacturing bulk drugs and finished formulations	-	Convergent, Aresko	55/100
5th	Indoco Remedies 1947, Mumbai (India), Public	Provider of APIs manufacturing and formulation services	-	Baring Private Equity Partners	54/100
6th	Wanbury Limited 1990, Mumbai (India), Public	Manufacturer of anti-diabetic drugs	-	-	53/100
7th	Galenicum 2003, Barcelona (Spain), Late Stage	Turnkey solutions for drug development, manufacturing and regulatory approvals	-	Peninsula Capital	52/100
8th	Amino 1958, Frellstedt (Germany), Unfunded	CDMO focused on amino acids and small molecules	-	-	51/100
9th	Aizant 2005, Hyderabad (India), Series A	Company offering contract development services for small molecules	$7.59M	Zephyr Management, Zephyr Peacock & 39 others	50/100
10th	Asymchem 1995, Morrisville (United States), Public	CDMO providing comprehensive pharmaceutical development and manufacturing solutions globally	-	Hillhouse, CoStone Capital & 5 others	50/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Jagsonpal's competitors? Click here to see the top ones

Jagsonpal has made 2 investments in companies including Zingavita and Naari. Jagsonpal has also acquired 3 companies including Group Pharma and Aequitas Healthcare.

Here is the list of investments & acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Sep 24, 2026	Acquisition	Group Pharma	1980	Mumbai (India)
Jun 29, 2026	Acquisition	Aequitas Healthcare	2017	Mumbai (India)
Jun 27, 2024	Acquisition	Yash Pharma	1972	Mumbai (India)